Chevy Chase Trust Holdings LLC decreased its position in The Clorox Company (NYSE:CLX – Free Report) by 0.7% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 84,720 shares of the company’s stock after selling 617 shares during the quarter. Chevy Chase Trust Holdings LLC’s holdings in Clorox were worth $12,971,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Point72 Asset Management L.P. purchased a new stake in shares of Clorox during the fourth quarter worth about $144,844,000. Norges Bank purchased a new position in Clorox during the 4th quarter valued at approximately $128,382,000. Parsifal Capital Management LP purchased a new position in Clorox during the 4th quarter valued at approximately $128,245,000. Confluence Investment Management LLC purchased a new position in Clorox during the 1st quarter valued at approximately $135,630,000. Finally, International Assets Investment Management LLC grew its holdings in Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after buying an additional 481,725 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.
Clorox Stock Up 1.4 %
NYSE CLX traded up $1.78 on Wednesday, reaching $133.63. 511,820 shares of the stock traded hands, compared to its average volume of 1,244,720. The company has a market cap of $16.60 billion, a price-to-earnings ratio of 69.27, a PEG ratio of 1.97 and a beta of 0.39. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.14. The company has a fifty day moving average price of $134.97 and a 200-day moving average price of $143.35.
Analyst Ratings Changes
Several equities analysts have weighed in on CLX shares. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target for the company in a report on Tuesday, March 26th. DA Davidson reiterated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Barclays dropped their target price on Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a report on Thursday, May 2nd. Citigroup dropped their target price on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Finally, Evercore ISI dropped their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a report on Wednesday, May 1st. Five research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $145.00.
View Our Latest Report on Clorox
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- What is the Dow Jones Industrial Average (DJIA)?
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- 5 Top Rated Dividend Stocks to Consider
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- 3 REITs to Buy and Hold for the Long Term
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.